Filter
538
Text search:
experimental
drug
Featured
Recommendations
43
New Publications
96
Language
Document type
No document type
312
Studies & Reports
93
Guidelines
71
Manuals
28
Strategic & Response Plan
11
Training Material
7
Fact sheets
7
Situation Updates
5
Resource Platforms
4
Countries / Regions
India
26
Global
18
Western and Central Europe
16
Latin America and the Carribbean
12
Kenya
11
Ethiopia
9
Rwanda
9
South Africa
9
Sierra Leone
7
Uganda
6
Ukraine
6
Liberia
5
Nigeria
5
Germany
5
Tanzania
5
Bangladesh
5
Brazil
5
Eastern Europe
5
Ghana
4
Zimbabwe
4
Nepal
4
South Sudan
4
Africa
4
Russia
4
Congo, Democratic Republic of
3
USA
3
Philippines
3
Malawi
3
Argentina
3
Colombia
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Burkina Faso
2
Senegal
2
Cameroon
2
Haiti
2
Zambia
2
Indonesia
2
Eswatini/ Swaziland
2
Lesotho
2
Eastern Europe and Central Asia
2
Venezuela
2
Tajikistan
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Syria
1
Thailand
1
China
1
Mozambique
1
Namibia
1
Peru
1
Botswana
1
Yemen
1
East and Southern Africa
1
Paraguay
1
Asia
1
Canada
1
Uzbekistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
60
Public Health
36
Women & Child Health
12
Key Resources
11
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
Mental Health
97
TB
43
HIV
38
COVID-19
38
Ebola
32
NTDs
30
Rapid Response
27
Pharmacy
21
AMR
19
Caregiver
15
Planetary Health
12
NCDs
11
Disability
10
Global Health Education
6
Zika
4
Conflict
3
Refugee
3
Health Financing Toolbox
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Standard Treatment Guideline
THELANCETID-D-16-00800 S1473-3099(16)30318-8
This is the third guidance note in a four-part series of notes related to impact evaluation developed by InterAction with financial support from the Rockefeller Foundation.This third guidance note, Introduction to Mixed Methods in Impact Evaluation, starts by explaining what a mixed methods (MM) imp
...
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Guidelines for the Management and Therapy of Urinary Tract Infection and Male Genitalia in Indonesia
Technical Series on Safer Primary Care